All stocks
LUPIN
Large CapLupin · Pharma
₹2,117.9
-0.66% today
Market Cap
₹92,000 Cr
CMP
₹2,117.9
52W High
₹3,072.5
52W Low
₹1,630.8
P/E
34.2
P/B
5.1
ROCE
18.2%
Div Yield
0.85%
Peer comparison
6 companies · Pharma and nearest by size. Current company highlighted — click a header to sort.
| Company | CMP | MCap (Cr) | P/E | P/B | ROCE | ROE | D/E | Sales 3Y | Profit 3Y | OPM | Div Yld |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | ₹1,945 | 4,45,000 | 38.2 | 6.4 | 18.9% | 16.8% | 0.04 | +16.6% | +22.4% | 24.1% | 0.76% |
| LUPIN | ₹2,363.5 | 92,000 | 34.2 | 5.1 | 18.2% | 16.4% | 0.12 | +16.8% | +19.3% | 23.8% | 0.85% |
| DABUR | ₹410 | 92,000 | 48.2 | 9.4 | 23.1% | 19.8% | 0.06 | +20.7% | +20.1% | 27.3% | 0.39% |
| PERSISTENT | ₹5,475 | 88,000 | 62.1 | 16.8 | 30.1% | 24.2% | 0.05 | +25.8% | +28.3% | 35.6% | 0.1% |
| AUROPHARMA | ₹1,658 | 78,000 | 21.8 | 2.6 | 14.1% | 12.8% | 0.18 | +14.2% | +11.4% | 18.4% | 1.13% |
| GRANULES | ₹873.85 | 14,000 | 28.2 | 3.8 | 16.8% | 14.1% | 0.32 | +16% | +18.5% | 21.2% | 1.53% |
Quarterly results
Last 8 quarters (₹ Cr unless noted)
| Quarter | Revenue | Op Profit | OPM | Other Inc | Interest | Dep | PBT | Tax | Net Profit | EPS | QoQ | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 FY25 | 3,250 | 803 | 24.7% | 41 | 35 | 103 | 705 | 164 | 541 | 13.9 | — | — |
| Q4 FY25 | 3,324 | 767 | 23.1% | 34 | 34 | 123 | 645 | 165 | 480 | 12.32 | -11.3% | — |
| Q1 FY26 | 3,330 | 774 | 23.2% | 57 | 22 | 104 | 705 | 169 | 537 | 13.79 | +11.9% | — |
| Q2 FY26 | 3,455 | 762 | 22% | 18 | 29 | 89 | 662 | 152 | 510 | 13.1 | -5% | — |
| Q3 FY26 | 3,650 | 818 | 22.4% | 67 | 38 | 74 | 773 | 197 | 576 | 14.79 | +12.9% | +6.5% |
| Q4 FY26 | 3,843 | 867 | 22.6% | 27 | 34 | 152 | 709 | 157 | 552 | 14.19 | -4.2% | +15% |
| Q1 FY27 | 3,855 | 943 | 24.5% | 60 | 39 | 94 | 871 | 208 | 663 | 17.03 | +20.1% | +23.5% |
| Q2 FY27 | 3,893 | 949 | 24.4% | 36 | 19 | 114 | 852 | 210 | 642 | 16.49 | -3.2% | +25.9% |
Profit & Loss — Annual
Last 4 years (₹ Cr)
| Year | Revenue | Op Profit | OPM | Net Profit | EPS | Tax Rate | Sales Growth | Profit Growth |
|---|---|---|---|---|---|---|---|---|
| FY23 | 13,937 | 3,151 | 22.6% | 2,077 | 53.36 | 23.5% | — | — |
| FY24 | 16,207 | 3,672 | 22.7% | 2,388 | 61.35 | 27.4% | +16.3% | +15% |
| FY25 | 19,215 | 4,330 | 22.5% | 2,725 | 70 | 27.4% | +18.6% | +14.1% |
| FY26 | 22,221 | 5,298 | 23.8% | 3,526 | 90.59 | 26.4% | +15.6% | +29.4% |
Balance sheet
Last 8 quarters (₹ Cr)
| Quarter | Share Capital | Reserves | Borrowings | Other Liab | Fixed Assets | CWIP | Investments | Other Assets | Total |
|---|---|---|---|---|---|---|---|---|---|
| Q3 FY25 | 902 | 15,617 | 1,949 | 5,166 | 9,180 | 1,329 | 4,326 | 8,800 | 23,634 |
| Q4 FY25 | 902 | 15,900 | 1,978 | 5,326 | 8,268 | 1,127 | 5,342 | 9,369 | 24,106 |
| Q1 FY26 | 902 | 16,354 | 1,968 | 4,443 | 8,368 | 1,019 | 4,961 | 9,319 | 23,666 |
| Q2 FY26 | 902 | 16,909 | 2,239 | 3,847 | 8,435 | 1,103 | 4,408 | 9,950 | 23,897 |
| Q3 FY26 | 902 | 17,438 | 2,311 | 3,872 | 9,229 | 1,296 | 5,646 | 8,353 | 24,524 |
| Q4 FY26 | 902 | 17,883 | 1,996 | 4,182 | 8,766 | 1,254 | 5,573 | 9,370 | 24,963 |
| Q1 FY27 | 902 | 18,185 | 2,220 | 3,998 | 9,727 | 1,185 | 4,793 | 9,600 | 25,305 |
| Q2 FY27 | 902 | 18,781 | 2,297 | 5,055 | 9,421 | 899 | 4,961 | 11,753 | 27,035 |
Cash flow
| Year | Operating | Investing | Financing | Net |
|---|---|---|---|---|
| FY23 | 2,338 | -1,176 | -600 | 562 |
| FY24 | 3,073 | -1,862 | -1,444 | -233 |
| FY25 | 2,939 | -1,584 | -1,921 | -566 |
| FY26 | 4,431 | -3,974 | -2,861 | -2,404 |
Shareholding pattern
PromoterGovtFIIDIIPublicOthers
Q3'25
Q4'25
Q1'26
Q2'26
Q3'26
Q4'26
Q1'27
Q2'27
Ratios
Last 4 years, with trend
| Ratio | FY23 | FY24 | FY25 | FY26 | Trend |
|---|---|---|---|---|---|
| Debtor Days | 67 | 59 | 32 | 59 | |
| Inventory Days | 70 | 42 | 41 | 72 | |
| Payable Days | 54 | 73 | 47 | 57 | |
| Cash Conversion Cycle | 83 | 28 | 26 | 74 | |
| Working Capital Days | 90 | 27 | 28 | 81 | |
| ROCE % | 15.9 | 17 | 17.4 | 18.2 | |
| ROE % | 13.7 | 15.3 | 15.4 | 16.5 | |
| OPM % | 22.6 | 22.7 | 22.5 | 23.8 |
Statement figures on this page are illustrative demo data until this company is scraped by the data pipeline. For educational purposes only. Not investment advice.